Giovanni Luca Ceresoli: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Giovanni Luca Ceresoli

Dr. Giovanni Luca Ceresoli is the Head of Pneumology and Oncology at the Urological Hospital Humanitas Gavazzeni Section in Bergamo, Italy.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Ceresoli will present on “The Current State of Renal Oncology in Italy.” His presentation will highlight:

• The evolving landscape of renal cancer diagnosis, management, and research in Italy.

• Challenges faced by the Italian healthcare system in providing optimal renal oncology care.

• Advances in integrated clinical approaches, combining radiotherapy, medical oncology, and surgery.

• Prospects for future collaborations and innovations to improve patient outcomes in renal cancer across Italy.

Dr. Ceresoli brings a multidisciplinary perspective and strong clinical expertise, emphasizing comprehensive and patient-centered care for renal oncology patients within the Italian healthcare context.

Global Voices in Renal Oncology (VIRO) 2025